Robert W. DeSimone
Wesleyan University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Robert W. DeSimone.
Tetrahedron Letters | 1989
Peter A. Jacobi; Charles A. Blum; Robert W. DeSimone; Uko E. Udodong
Abstract (−)-Norsecurinine ( 1a ) has been prepared in a stereospecific fashion beginning with the acetylenic oxazole 18 . Diels-Alder cyclization of 18 afforded the furanoketone 19 , which was transformed in five steps to the butenolide mesylate 24 . Transannular alkylation of 24 then afforded 1a . In identical fashion, ent- 18 gave (+)-norsecurinine ( 1b ).
Bioorganic & Medicinal Chemistry Letters | 2009
Scott Mitchell; Mihaela Diana Danca; Peter Blomgren; James W. Darrow; Kevin S. Currie; Jeffrey E. Kropf; Seung Ho Lee; Steven L. Gallion; Jin-Ming Xiong; Douglas A. Pippin; Robert W. DeSimone; David R. Brittelli; David C. Eustice; Aaron Bourret; Melissa Hill-Drzewi; Patricia Maciejewski; Lisa Elkin
Inhibition of receptor tyrosine kinases (RTKs) such as vascular endothelial growth factor receptors (VEGFRs) and platelet-derived growth factor receptors (PDGFRs) has been validated by recently launched small molecules Sutent and Nexavar, both of which display activities against several angiogenesis-related RTKs. EphB4, a receptor tyrosine kinase (RTK) involved in the processes of embryogenesis and angiogenesis, has been shown to be aberrantly up regulated in many cancer types such as breast, lung, bladder and prostate. We propose that inhibition of EphB4 in addition to other validated RTKs would enhance the anti-angiogenic effect and ultimately result in more pronounced anti-cancer efficacy. Herein we report the discovery and SAR of a novel series of imidazo[1,2-a]pyrazine diarylureas that show nanomolar potency for the EphB4 receptor, in addition to potent activity against several other RTKs.
Tetrahedron Letters | 1992
Peter A. Jacobi; Robert W. DeSimone
Abstract Formal syntheses of pyrromethenones 2 and 3 , potential intermediates for the preparation of phycocyanin ( 5 ) and phytochrome ( 4 ), respectively, have been accomplished by Pd o mediated coupling of iodopyrrole 7 with acetylenic amides of general structure 8a,b followed by F- catalyzed 5-exo-dig cyclization and DDQ oxidation.
Bioorganic & Medicinal Chemistry Letters | 2000
Robert W. DeSimone; Charles A. Blum
A novel class of potent benzodiazepine receptor (BZR) ligands has been designed and synthesized aided by molecular modeling of known benzodiazepine ligands such as CGS-8216 and the use of known pharmacophore models.
Archive | 2001
Rajagopal Bakthavatchalam; Alan Hutchison; Robert W. DeSimone; Keven J. Hodgetts; James E. Krause; Geoffrey White
Archive | 2003
Kevin S. Currie; Robert W. DeSimone; Douglas A. Pippin; James W. Darrow; Scott A. Mitchell
Archive | 2004
Kevin S. Currie; Robert W. DeSimone; Scott A. Mitchell; Douglas A. Pippin; James W. Darrow; Xiaobing Qian; Mark Velleca; Dapeng Qian
Archive | 2004
Kevin S. Currie; Robert W. DeSimone; Scott A. Mitchell; Douglas A. Pippin
Archive | 2004
Scott A. Mitchell; Kevin S. Currie; Robert W. DeSimone; Douglas A. Pippin
Archive | 2004
Kevin S. Currie; Robert W. DeSimone; Douglas A. Pippin; James W. Darrow; Scott A. Mitchell